hepat
b
viru
hbv
lead
caus
liverrel
death
asia
africa
although
effect
vaccin
decad
persist
exist
hbv
replic
independ
risk
factor
liver
cirrhosi
hepatocellular
carcinoma
hcc
antivir
therapi
base
current
option
recombin
interferon
ifn
nucleotidenucleosid
analog
markedli
reduc
incid
liver
cirrhosi
hcc
howev
hardli
elimin
hbv
infect
suppress
viral
replic
limit
detect
complet
prevent
hcc
develop
although
liver
fibrosi
stop
exampl
nucleosid
analog
lamivudin
treatment
cumul
hcc
rate
year
patient
chronic
hepat
b
chb
liver
cirrhosi
even
effect
lower
resist
entecavir
etv
five
yeartreat
reduc
hcc
risk
patient
chb
advanc
liver
fibrosi
cumul
hcc
rate
year
situat
even
wors
matter
etv
lamivudin
use
rate
patient
chb
liver
cirrhosi
respect
thu
remain
imper
search
new
therapeut
target
hbv
infect
hcc
develop
hbv
hepatotrop
envelop
viru
partial
doublestrand
circular
viral
genom
viral
genom
packag
insid
capsid
assembl
viral
core
protein
hepat
b
core
antigen
hbcag
gener
nucleocapsid
cytosol
viral
envelop
mainli
consist
smallsurfac
protein
hepat
b
surfac
antigen
hbsag
small
surfac
protein
addit
extens
middl
surfac
protein
larg
surfac
protein
nterminu
protein
cotransl
integr
endoplasm
reticulum
er
membran
penetr
er
lumen
viral
nucleocapsid
packag
transmembran
protein
gener
matur
virion
life
cycl
hbv
also
synthes
secretori
core
protein
final
matur
hepat
b
e
antigen
hbeag
synthesi
nascent
peptid
chain
direct
er
signal
sequenc
develop
hbeag
precursor
signal
sequenc
remov
hbeag
precursor
digest
furin
golgi
apparatu
gener
matur
hbeag
hbeag
precursor
detain
er
undigest
furin
retrotransport
cytosol
express
surfac
hepatocyt
hbeag
releas
bloodstream
serv
immunotoler
induc
contrast
hbeag
precursor
cell
surfac
chanc
initi
antivir
immun
cytosol
inhibit
hbv
replic
via
format
capsidationincompet
capsid
hbcag
glucoseregul
protein
constitut
express
er
involv
major
function
er
transloc
newli
synthes
polypeptid
across
er
membran
facilit
fold
secret
protein
target
misfold
unnecessari
protein
erassoci
protein
degrad
serv
er
stress
sensor
releas
cell
stress
condit
regard
hbv
infect
least
involv
four
import
process
viral
replic
viral
secret
hbeag
secret
hbvrelat
hepatocellular
carcinogenesi
report
inhibit
hbv
replic
facilit
hbv
transcript
degrad
via
activ
synthetasernas
l
pathway
promot
virion
secret
via
guid
posttransl
er
transloc
hbv
larg
envelop
protein
enhanc
retrotransport
hbeag
precursor
er
cytosol
may
affect
hbeag
secret
facilit
migrat
invas
hcc
via
reduct
er
stressinduc
apoptosi
express
cellsurfac
confer
drug
resist
effect
hbv
replic
inhibit
suggest
upregul
therapeut
potenti
chronic
hbv
infect
rest
effect
promot
virion
secret
hcc
invas
argu
potenti
contradictori
effect
let
us
know
overal
effect
hbv
product
make
choic
util
antihbv
effect
upregul
cancerprev
effect
downregul
futur
studi
overal
effect
found
decreas
hbv
product
due
hbv
replicationinhibitori
effect
timedepend
overwhelm
virion
secretionpromot
effect
cell
also
inhibit
hbeag
secret
via
enhanc
retrotransport
hbeag
precursor
howev
overexpress
significantli
increas
motil
cell
contrast
knockdown
accumul
intracellular
hbv
dna
increas
hbeag
secret
fortun
abrog
cotreat
etv
furin
inhibitor
hexdarginin
respect
find
clarifi
overal
effect
hbv
replic
mani
implic
strategi
search
order
cover
hcc
prevent
shortag
current
antivir
therapi
futur
report
promot
secret
hbv
particl
cell
act
intracellular
antihbv
factor
cell
line
tetoff
promot
control
hbv
product
though
report
use
sirna
downregul
decreas
increas
supernat
hbv
particl
observ
respect
discord
may
result
differ
cell
model
compar
cell
cell
produc
hbv
particl
continu
manner
better
mimic
persist
infect
state
patient
reason
cell
use
studi
clarifi
overal
effect
hbv
product
success
upregul
downregul
transfect
recombin
express
plasmid
sirna
respect
fig
overexpress
reduc
supernat
intracellular
coreassoci
hbv
dna
knockdown
show
opposit
effect
fig
c
regularli
detect
two
band
perhap
due
splice
variat
though
cell
model
use
effect
opposit
report
publish
literatur
may
result
use
differ
observ
time
h
studi
h
literatur
test
possibl
supernat
coreassoci
hbv
dna
detect
h
transfect
fig
result
inde
moder
increas
supernat
level
hbv
particl
furthermor
found
inhibit
hbv
product
slightli
h
significantli
h
transfect
result
suggest
hbv
replicationinhibit
effect
timedepend
overwhelm
viral
secretionpromot
effect
mainli
inhibit
hbv
product
patient
persist
infect
reduc
hbv
product
inhibit
viral
dna
replic
fig
howev
underli
mechan
cell
unclear
yet
base
find
cell
parent
cell
report
inhibit
hbv
replic
activ
synthetasernas
l
pathway
wonder
whether
similarli
inhibit
hbv
replic
cell
unexpectedli
overexpress
knockdown
significantli
affect
mrna
level
rnase
l
gene
fig
protein
level
fig
cell
clarifi
reason
behind
deviat
cell
compar
express
level
gene
interest
two
cell
line
result
mrna
level
rnase
l
gene
cell
cell
respect
fig
similarli
protein
level
cell
much
lower
cell
fig
result
ascertain
pathway
block
inhibit
hbv
replic
pathway
cell
erresid
chaperon
protein
report
specif
coimmunoprecipit
hbeag
precursor
assist
retrotransport
er
cytosol
addit
hbeag
precursor
cytosol
potenti
inhibit
hbv
replic
format
encapsidationincompet
hybrid
capsid
core
protein
therefor
may
inhibit
hbv
replic
promot
effect
cytosol
retrotransport
hbeag
precursor
addit
enhanc
retrotransport
hbeag
precursor
may
reduc
hbeag
synthesi
meaning
hbeag
seroconvers
clinic
practic
inde
overexpress
result
increas
cytosol
hbeag
precursor
decreas
hbeag
secret
fig
b
contrast
knockdown
show
opposit
effect
band
vari
hbeag
corerel
peptid
modif
degrad
differ
degre
result
ascertain
antihbv
effect
suggest
inhibit
hbv
replic
promot
retrotransport
hbeag
precursor
er
cytosol
cell
result
indic
inhibit
hbv
product
hbeag
secret
correl
virolog
serolog
respons
clinic
practic
suggest
upregul
antihbv
strategi
somewhat
better
current
viral
polymeraseselect
inhibitor
howev
increas
data
impli
involv
invas
migrat
hcc
cancer
sinc
result
show
unlik
hepatoma
cell
line
hbv
inhibit
pathway
cell
mobil
effect
cell
line
studi
result
overexpress
found
promot
wound
heal
h
transfect
fig
b
promot
result
enhanc
cell
mobil
rather
possibl
effect
cell
prolifer
sinc
prolifer
status
cell
without
overexpress
similar
fig
hcc
fatal
complic
chronic
hbv
infect
prophylaxi
current
antivir
option
far
satisfact
base
characterist
inhibit
hbv
secret
cancer
invas
downregul
may
promis
supplement
current
antivir
option
howev
downregul
significantli
increas
hbv
replic
hbeag
secret
fig
previou
studi
shown
etv
broadli
accept
antivir
drug
clinic
practic
combin
furin
inhibitor
moder
inhibit
hbeag
secret
unlik
common
furin
inhibitor
enhanc
hbv
replic
inhibit
hbv
replic
hbeag
secret
simultan
reason
examin
whether
etv
cope
unpleas
effect
fortun
etv
complet
abolish
hbv
replicationenhanc
effect
knockdown
though
effect
moder
reduc
fig
b
similarli
complet
abolish
hbeag
secretionenhanc
effect
fig
contradictori
effect
hbv
life
cycl
inhibit
hbv
replic
promot
hbv
secret
studi
overal
effect
found
decreas
hbv
product
due
hbv
replicationinhibitori
effect
timedepend
overwhelm
virion
secretionpromot
effect
cell
probabl
due
hbv
replic
upstream
event
viral
life
cycl
impli
mainli
inhibit
hbv
replic
patient
persist
infect
inde
overexpress
show
antihbv
effect
decreas
hbv
dna
replic
hbeag
secret
impli
favor
common
antivir
goal
undetect
hbv
dna
hbeag
seroconvers
clinic
practic
howev
overexpress
increas
mobil
cell
base
wound
heal
test
impli
involv
hcc
tumorigenesi
dim
clinic
prospect
upregul
also
suggest
knockdown
may
favor
hcc
prevent
howev
knockdown
found
increas
hbv
replic
hbeag
secret
therefor
find
impli
downregul
suitabl
serv
supplementari
strategi
improv
hcc
prevent
efficaci
current
antivir
option
enhanc
hbv
replic
hbeag
secret
effect
block
mechan
inhibit
hbv
replic
well
secret
hbsag
hbeag
complet
clarifi
overexpress
upregul
express
rnase
l
gene
treatment
return
upregul
express
cell
impli
antihbv
mechan
correl
pathway
howev
studi
found
cell
express
much
less
constitut
rnase
l
compar
cell
concord
report
scientist
addit
overexpress
knockdown
significantli
affect
express
mention
gene
hand
found
promot
retrotransport
hbeag
precursor
er
cytosol
cell
welldocu
cytosol
hbeag
precursor
inhibit
hbv
replic
format
hbv
encapsidationincompet
capsid
therefor
result
ascertain
pathway
block
cell
inhibit
hbv
replic
promot
retrotransport
hbeag
precursor
er
cytosol
restor
vigor
pathway
may
new
strategi
treat
chb
futur
immun
toler
major
factor
underli
mainten
chronic
hbv
infect
hbeag
immunotoler
induc
play
key
role
mainten
immun
toler
shown
fact
hbeagdefect
variant
rare
caus
de
novo
chronic
infect
hbeag
modul
host
immun
respons
hbcag
studi
found
inhibit
hbeag
secret
via
enhanc
retrotransport
hbeag
precursor
meaning
hbeag
seroconvers
import
treatment
endpoint
clinic
practic
well
document
facilit
invas
hcc
cancer
perhap
due
persist
exist
hbv
cell
unlik
hepatoma
cell
line
hbv
inhibit
pathway
howev
base
wound
heal
test
effect
mobil
cell
similar
hbvfree
cell
line
addit
usual
highli
express
hcc
tissu
express
level
posit
correl
portal
intrahepat
invas
hcccontribut
mechan
includ
allevi
er
stress
mediat
loss
tumor
suppressor
pten
enhanc
activ
activ
fak
thu
ascertain
substanti
involv
hcc
tumorigenesi
hcc
fatal
complic
chronic
hbv
infect
possibl
upregul
antihbv
strategi
seem
dismiss
unless
upregul
lead
rapid
elimin
chronic
hbv
infect
earli
stage
unfortun
well
known
elimin
chronic
hbv
infect
ambiti
expect
current
hcc
prevent
efficaci
current
antivir
option
urg
improv
especi
patient
liver
cirrhosi
ontreat
cumul
hcc
rate
year
patient
chb
cirrhosi
ontreat
cumul
hcc
rate
year
patient
chb
cirrhosi
view
effect
hcc
downregul
may
potenti
supplementari
measur
improv
hcc
prevent
efficaci
current
antivir
therapi
inde
knockdown
may
decreas
invas
capabl
reduc
risk
resist
sorafenib
enhanc
adenosineinduc
apoptosi
howev
articl
report
opposit
effect
downregul
enhanc
migrat
abil
cell
line
hcc
perhap
due
uniqu
pattern
express
addit
downregul
enhanc
hbv
replic
hbeag
secret
though
unpleas
effect
abrog
etv
furin
inhibitor
respect
therefor
therapeut
target
potenti
substanti
limit
urg
intens
studi
futur
although
mainli
demonstr
antihbv
effect
suitabl
antihbv
target
due
potenti
risk
hcc
invas
fortun
downregul
potenti
addit
strategi
cover
hcc
prevent
shortag
current
antivir
therapi
recombin
plasmid
origin
plasmid
name
pvector
studi
purchas
origen
technolog
rockvil
md
usa
small
interf
rna
sirna
augcu
gacau
ugaa
neg
control
sirna
sever
acut
respiratori
syndrom
coronaviru
sicontrol
ugucu
accuu
gaug
synthes
ribobio
corpor
guangzhou
china
cell
grown
dulbecco
modifi
eagl
medium
fetal
bovin
serum
cell
medium
supplement
geneticin
cell
transfect
pvector
nmoll
sicontrol
respect
transfect
perform
plate
su
lipofectamin
invitrogen
corpor
shanghai
china
accord
manufactur
instruct
abolish
effect
downregul
hbv
replic
hbeag
secret
cell
treat
nmoll
etv
sigmaaldrich
corpor
st
loui
mo
usa
emd
bioscienc
la
jolla
ca
usa
respect
evalu
hbv
replic
express
cell
harvest
h
transfect
unless
otherwis
indic
detect
total
cellular
protein
prepar
lyse
cell
ice
min
lysi
buffer
mmoll
tri
ph
mmoll
nacl
sd
mmoll
phenylmethylsulfonyl
fluorid
mgl
aprotinin
mgl
leupeptin
detect
intercellular
hbcag
hbeag
hbeag
precursor
cytosol
noncytosol
cellular
protein
separ
extract
report
briefli
cell
membran
cautious
broken
ice
digitonin
buffer
mmoll
tri
ph
mmoll
nacl
mgl
digitonin
mmoll
phenylmethylsulfonyl
fluorid
mgl
aprotinin
mgl
leupeptin
cytosol
fraction
cell
lysat
includ
solubl
cellular
protein
noncytosol
fraction
includ
cellular
protein
remain
cell
debri
nucleu
endoplasm
reticulum
golgi
complex
extract
independ
sampl
normal
total
cellular
cytosol
noncytosol
protein
total
sort
cellular
protein
separ
transfer
onto
polyvinyliden
fluorid
membran
millipor
corpor
billerica
usa
use
standard
techniqu
immunoblot
analysi
perform
use
polyclon
antibodi
human
novu
biolog
littleton
co
usa
novu
biolog
hbcag
dako
carpinteria
ca
usa
enhanc
chemiluminesc
reagent
invitrogen
corpor
shanghai
china
isol
supernat
intracellular
core
particl
perform
report
coreassoci
hbv
dna
extract
use
phenolchloroform
digest
mgl
proteinas
k
h
supernat
coreassoci
hbv
dna
quantit
examin
use
realtim
fluoresc
polymeras
chain
reaction
pcr
taan
gene
compani
guangzhou
china
intracellular
coreassoci
hbv
dna
detect
use
southern
blot
analysi
sampl
balanc
base
protein
level
cell
lysat
isol
dna
separ
transfer
onto
nylon
membran
roch
appli
scienc
indianapoli
usa
hybrid
digoxigeninlabel
dna
probe
membran
incub
horseradish
peroxidaselabel
antidigoxigenin
antibodi
roch
appli
scienc
develop
enhanc
chemiluminesc
reagent
invitrogen
corpor
cellular
total
rna
extract
use
trizol
invitrogen
corpor
accord
manufactur
instruct
dnase
ambion
austin
tx
usa
treatment
quantif
photospectrometri
rna
puriti
assess
electrophoresi
agaros
gel
ng
total
rna
revers
transcrib
reaction
promega
madison
wi
usa
accord
kit
manufactur
protocol
rel
mrna
level
rnase
l
dehydrogenas
gapdh
housekeep
control
quantifi
use
sybr
green
realtim
pcr
kit
takana
bio
otsu
japan
primer
follow
bp
forward
gacca
acaag
tgtct
cctcc
aaa
revers
gaact
gctgc
agctg
cttaa
tc
rnase
l
bp
forward
ttgag
gcgaa
agaca
aagga
g
revers
gtcac
aggcg
tttac
atctg
c
gapdh
bp
forward
gtgaa
ggctg
revers
aagac
gccag
reaction
perform
use
revers
transcript
product
sampl
three
run
realtim
pcr
perform
everi
sampl
amplif
conduct
anneal
temperatur
cycl
end
program
melt
curv
analysi
carri
data
rnase
l
normal
use
express
housekeep
gene
gapdh
order
ensur
compar
hbeag
media
quantifi
use
commerci
kit
chemiluminesc
immunoassay
uscnk
life
scienc
incorpor
wuhan
china
cell
monolay
without
overexpress
care
wound
steril
pipett
remov
debri
time
wash
pb
monolay
cultur
dulbecco
modifi
eagl
medium
contain
fetal
bovin
serum
h
photograph
microscop
taken
immedi
wound
incis
time
point
h
would
closur
ratio
initi
width
later
width
initi
width
ten
would
closur
ratio
differ
locat
calcul
monolay
cell
prolifer
assay
steril
bromid
mtt
solut
mgml
ad
well
cell
incub
h
normal
cultur
condit
absorb
nm
measur
use
micropl
reader
crystal
dissolv
dimethylsulfoxid
differ
supernat
hbv
dna
hbeag
mrna
level
rnase
l
wound
closur
ratio
cell
prolifer
analyz
use
student
ttest
base
data
three
independ
experi
normal
consist
three
independ
test
p
consid
statist
signific
statist
analys
conduct
use
spss
softwar
version
spss
incorpor
chicago
il
usa
